Gene Editing Market

Global Gene Editing Market by Technology (CRISPR, TALEN, and ZFN), End-users (Pharmaceutical, Biotechnology, and Academia), Applications (Cell Line Engineering, Genetic Engineering, and Diagnostics), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-3943
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 165
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global gene editing market is expected to grow at a substantial CAGR during the forecast period of 2021-2028. Current developments in gene editing processes have helped the market to reach new heights in the gene editing abilities due to wide advancement in technology for the modification of gene sequences and arrangements of model organisms and cell types. Gene engineering, widely adopted by several research organizations, are increasingly used by government-based research centres and academia and it has now become a great tool for transformative diagnostic and most importantly for oncology studies. The wide application of the process among academics to clinical and diagnostic laboratories is basically influenced by swift changes in gene editing technology. The COVID-19 pandemic has caused problems for many biotechnological and pharmaceutical companies and other players associated with the genomic market as there was radical shift to invest in vaccine research and development of the coronavirus.

Gene Editing Market key takeaways

Market Trends, Drivers, Restraints, and Opportunities:

  • Significant investment in the field of genomics from key players with setting objectives for the development of new technology in gene editing process is expected to boost the market growth during the forecast period.
  • Wide involvement of government funding to enable academic and government institutes to carry out in-depth research related to gene editing as well as engineering is a key driver of the market expansion.
  • Growth in the personalized medicine market and wide occurrence of gene disorder diseases are expected to offer immense opportunities to players in the gene editing market.
  • High cost of gene editing instruments is a major challenge projected to hamper the market growth during the forecast period. The devices equipped with advanced features and high functionalities are normally priced at a range of USD 10-20 million.

Scope of the report:

The report on the global gene editing market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Gene Editing Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Technology (CRISPR, TALEN, and ZFN), End-users (Pharmaceutical, Biotechnology, and Academia), Applications (Cell Line Engineering, Genetic Engineering, and Diagnostics)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered

Thermo Fisher Scientific Inc.; Merck KGaA; and GenScript

 

Gene Editing Market Segment Insights:

CRISPR segment is projected to account for a significant market share

In terms of the technology, the market is divided into CRISPR, TALEN, and ZFN. The CRISPR segment dominated the market in 2020 and is projected to account for a significant market share during the projected period. The growth of the segment is attributed to wide adoption of the technique as it offers certain practical benefits the genome modification and sequencing. Moreover, wide advantage in illness recovery due to high adoption of a guide RNA-specific, effective gene transformation, and favourable regulation are key aspects, which help to rise in the acceptance of CRISPR technology across hospitals and clinics. Moreover, the clinical uses of CRISPR are widely accepted worldwide due to growing number of gene-editing trails and rapid development of treatment techniques for various diseases such as AIDS, cancer, and genetic diseases. Moreover, this technology is further applied in various animal breeding and agriculture applications.

Pharmaceutical and biotechnological segments are likely to dominate the market

On the basis of end-users, the global gene editing market is segmented into pharmaceutical, biotechnology, and academia. The biotechnology and pharmaceutical segments are likely to dominate the market during the projected period owing to the growing number of research activities for novel therapeutic development for various applications. Moreover, global pharmaceutical companies are collaborating with newly emerging companies to develop novel technologies. However, the academia segment is projected to constitute a key market share in the coming years owing to wide government funding on research collaborated with academic institutes to expedite new genome study and experiments. The segment growth is further attributed to the increasing the number of gene-editing technologies in University-level projects along with active engagement of research institutes.

Gene Editing Market by end users

Cell line engineering segment is anticipated to expand at a robust growth rate

Based on applications, the market is segmented into cell line engineering, genetic engineering, and diagnostics. The cell line engineering segment is anticipated to expand at a robust growth rate in the coming years as the developments in gene editing systems have revolutionized the genetic engineering space, with cell line engineering at the forefront. The usage of CRISPR gene editing in human-induced pluripotent stem cells (hiPSCs) related programs has important effects in stem cell research for the treatment of various diseases. The CRISPR technology is widely being applied to enhance the productivity of CHO cell lines, which are prominently used in the production of large molecule therapeutics.

Gene Editing Market by applications

North America is projected to represent a high market share

In terms of regions, the global gene editing market is categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America accounted for a dominant share of the market, followed by Europe in 2020. The market of North America is projected to represent a high market share during the forecast period owing to the rapid development of gene therapy, increased use of GM crops, and rise in the availability of research grants and funding especially in the US. The market in Canada is expected to register substantial growth in the coming years owing to various government initiatives and the intensification of genomics R&D (through GAPP) in the country.

Segments

Segments covered in the report:

By Technology

  • CRISPR
  • TALEN
  • ZFN
By End-users
  • Pharmaceutical
  • Biotechnology
  • Academia
By Applications
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostics
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
By Key Players
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript

Competitive Landscape

Some of the key players in the market are Thermo Fisher Scientific Inc.; Merck KGaA; and GenScript. These players are actively engaged in various business development strategies including mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Gene Editing Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Gene Editing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Gene Editing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Gene Editing Market - Supply Chain
  4.5. Global Gene Editing Market Forecast
     4.5.1. Gene Editing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Gene Editing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Gene Editing Market Absolute $ Opportunity
5. Global Gene Editing Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Gene Editing Market Size and Volume Forecast by Applications
     5.3.1. Cell Line Engineering
     5.3.2. Genetic Engineering
     5.3.3. Diagnostics
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Gene Editing Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Gene Editing Market Size and Volume Forecast by End Users
     6.3.1. Pharmaceutical
     6.3.2. Biotechnology
     6.3.3. Academia
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Gene Editing Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Gene Editing Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Gene Editing Demand Share Forecast, 2019-2026
8. North America Gene Editing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Gene Editing Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Gene Editing Market Size and Volume Forecast by Applications
     8.4.1. Cell Line Engineering
     8.4.2. Genetic Engineering
     8.4.3. Diagnostics
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Gene Editing Market Size and Volume Forecast by End Users
     8.7.1. Pharmaceutical
     8.7.2. Biotechnology
     8.7.3. Academia
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Gene Editing Demand Share Forecast, 2019-2026
9. Latin America Gene Editing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Gene Editing Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Gene Editing Market Size and Volume Forecast by Applications
     9.4.1. Cell Line Engineering
     9.4.2. Genetic Engineering
     9.4.3. Diagnostics
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Gene Editing Market Size and Volume Forecast by End Users
     9.7.1. Pharmaceutical
     9.7.2. Biotechnology
     9.7.3. Academia
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Gene Editing Demand Share Forecast, 2019-2026
10. Europe Gene Editing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Gene Editing Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Gene Editing Market Size and Volume Forecast by Applications
     10.4.1. Cell Line Engineering
     10.4.2. Genetic Engineering
     10.4.3. Diagnostics
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Gene Editing Market Size and Volume Forecast by End Users
     10.7.1. Pharmaceutical
     10.7.2. Biotechnology
     10.7.3. Academia
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Gene Editing Demand Share Forecast, 2019-2026
11. Asia Pacific Gene Editing Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Gene Editing Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Gene Editing Market Size and Volume Forecast by Applications
     11.4.1. Cell Line Engineering
     11.4.2. Genetic Engineering
     11.4.3. Diagnostics
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Gene Editing Market Size and Volume Forecast by End Users
     11.7.1. Pharmaceutical
     11.7.2. Biotechnology
     11.7.3. Academia
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Gene Editing Demand Share Forecast, 2019-2026
12. Middle East & Africa Gene Editing Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Gene Editing Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Gene Editing Market Size and Volume Forecast by Applications
     12.4.1. Cell Line Engineering
     12.4.2. Genetic Engineering
     12.4.3. Diagnostics
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Gene Editing Market Size and Volume Forecast by End Users
     12.7.1. Pharmaceutical
     12.7.2. Biotechnology
     12.7.3. Academia
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Gene Editing Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Gene Editing Market: Market Share Analysis
  13.2. Gene Editing Distributors and Customers
  13.3. Gene Editing Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Thermo Fisher Scientific Inc.
     13.4.2. Merck KGaA
     13.4.3. GenScript

Segments covered in the report:

By Technology

  • CRISPR
  • TALEN
  • ZFN
By End-users
  • Pharmaceutical
  • Biotechnology
  • Academia
By Applications
  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostics
By Regions
  • North America
  • Europe
  • Latin America
  • Asia Pacific
By Key Players
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript

Some of the key players in the market are Thermo Fisher Scientific Inc.; Merck KGaA; and GenScript. These players are actively engaged in various business development strategies including mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Gene Editing Market by key players

Buy Report